Table 1.
Selected clinical data for 20 patients with primary Sjögren’s syndrome.
| Variables | High fatigue (n = 10) | Low fatigue (n = 10) | p |
|---|---|---|---|
| Age, yearsa | 61 (42–78) | 56 (36–68) | 0.16 |
| Gender (male/female) | 1/9 | 2/8 | 0.54 |
| Disease duration, yearsa | 10 (1–15) | 4 (2–11) | 0.09 |
| Hgb, g/dLa | 13 (12–14) | 13 (12–15) | 0.51 |
| ESR, mm/ha | 17 (6–31) | 7 (2–28) | 0.04 |
| CRP (mg/L)a | 3 (0–9) | 0 (0–4) | 0.05 |
| Anti-SSA/La abs | |||
| (Pos/neg) | 8/2 | 6/4 | 0.34 |
| Anti-SSB/Ro abs | |||
| (Pos/neg) | 4/6 | 4/6 | 1 |
| BDI scorea | 12 (8–27) | 7 (0–18) | 0.01 |
| Fatigue VAS scorea | 79 (76–91) | 13 (3–29) | < 0.001 |
| Medication | |||
| Prednisolone (%) | 3 (30) | 0 | |
| Antimalarials (%) | 2 (20) | 3 (30) | |
| Prednisolone and antimalarial (%) | 0 | 1 | |
BDI: Beck depression inventory; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; Hgb: hemoglobin; SSA/La abs: Sjögren’s syndrome A antibodies; SSB/Ro abs: Sjögren’s syndrome B antibodies; VAS: visual analog scale.
a
Results presented as median and range (Mann–Whitney U test).